Attorney General Phil Weiser secures over $12 million for Colorado from 8 opioid drugmakers

July 10, 2025 (DENVER) – Attorney General Phil Weiser today announced a multistate settlement with eight drugmakers that manufactured opioid pills and worsened the nationwide opioid crisis. In total, the settlement is worth approximately $720 million, of which Colorado could receive just over $12 million.

Because of the participation of a broad, bipartisan coalition of attorneys general across the country, all eight companies have agreed to proceed with a sign-on period for local governments.

“I’ve brought back hundreds of millions of dollars that are being put to use locally by communities to treat people dealing with opioid addiction and build the infrastructure needed to ensure long-term recovery,” said Attorney General Weiser. “With the federal government attempting to claw back investments in opioid treatment, every settlement dollar we secure is even more important. I will continue to hold accountable drugmakers and any other companies that knowingly pushed addictive products and fueled the opioid and addiction crisis.”

The eight companies and the total nationwide amount they will pay in funds to address the opioid crisis as part of the deal are:

  • Mylan (now part of Viatris): $284,447,916 paid over nine years
  • Hikma: $95,818,293 paid over one to four years
  • Amneal: $71,751,010 paid over 10 years
  • Apotex: $63,682,369 paid in a single year
  • Indivior: $38,022,450 paid over four years
  • Sun: $30,992,087 paid over one to four years
  • Alvogen: $18,680,162 paid in a single year
  • Zydus: $14,859,220 paid in a single year

Several of the settlements allow states to receive free pharmaceutical products or cash in lieu of this product. Additionally, the settlements with seven of the companies (not including Indivior) prohibit them from promoting or marketing opioids and opioid products, making or selling any product that contains more than 40 mg of oxycodone per pill, and require them to put in place a monitoring and reporting system for suspicious orders. Indivior has agreed not to manufacture or sell opioid products for the next 10 years, but it will be able to continue marketing and selling medications to treat opioid use disorder.

In total, the state is on track to receive over $880 million in opioid settlements.

Joining Colorado in negotiating the settlements were North Carolina, California, Illinois, New York, Oregon, Tennessee, Utah, and Virginia.

###

Media Contact:
Lawrence Pacheco
Chief Communications Officer
(720) 508-6553 office
lawrence.pacheco@coag.gov